Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan M Burt

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
The Annals of Thoracic Surgery|December 4, 2020
Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma With Routine Positron Emission Tomography ImagingR Taylor Ripley, Nihanth Palivela, Shawn S Groth, et al.
The Annals of Thoracic Surgery|August 29, 2021
Demographic Landscape of Cardiothoracic Surgeons and Residents at United States Training ProgramsJacqueline K Olive, Sanaa Mansoor, Katherine Simpson, et al.
Cancer Cell|June 21, 2024
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumorsGabriel Espinosa-Carrasco, Edison Chiu, Aurora Scrivo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2017
Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective DatabaseSukhmani K Padda, Xiaopan Yao, Alberto Antonicelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2022
Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma TumorsAmanda M Nash, Samira Aghlara-Fotovat, Bertha Castillio, et al.
The Annals of Thoracic Surgery|November 29, 2020
Prognostic Role of Programmed Cell Death 1 Ligand 1 in Resectable Pleural MesotheliomaHyun-Sung Lee, Masatsugu Hamaji, Nihanth Palivela, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 13, 2018
A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural MesotheliomaBryan M Burt, William G Richards, Hyun-Sung Lee, et al.
Nature|April 30, 2015
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunityYaron Carmi, Matthew H Spitzer, Ian L Linde, et al.
The Annals of Thoracic Surgery|September 30, 2021
Inhibition of Cyclin Dependent Kinase 4/6 Overcomes Primary Resistance to Programmed Cell Death 1 Blockade in Malignant MesotheliomaHee-Jin Jang, Cynthia Y Truong, Eric M Lo, et al.
JTO Clinical and Research Reports|July 30, 2024
Pathophysiology and Management of Chest Wall Pain after Surgical and Non-Surgical Local Therapies for Lung CancerJohn Nikitas, Jane Yanagawa, Sandra Sacks, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
The Annals of Thoracic Surgery|December 4, 2020
Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma With Routine Positron Emission Tomography ImagingR Taylor Ripley, Nihanth Palivela, Shawn S Groth, et al.
The Annals of Thoracic Surgery|August 29, 2021
Demographic Landscape of Cardiothoracic Surgeons and Residents at United States Training ProgramsJacqueline K Olive, Sanaa Mansoor, Katherine Simpson, et al.
Cancer Cell|June 21, 2024
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumorsGabriel Espinosa-Carrasco, Edison Chiu, Aurora Scrivo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2017
Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective DatabaseSukhmani K Padda, Xiaopan Yao, Alberto Antonicelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2022
Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma TumorsAmanda M Nash, Samira Aghlara-Fotovat, Bertha Castillio, et al.
The Annals of Thoracic Surgery|November 29, 2020
Prognostic Role of Programmed Cell Death 1 Ligand 1 in Resectable Pleural MesotheliomaHyun-Sung Lee, Masatsugu Hamaji, Nihanth Palivela, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 13, 2018
A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural MesotheliomaBryan M Burt, William G Richards, Hyun-Sung Lee, et al.
Nature|April 30, 2015
Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunityYaron Carmi, Matthew H Spitzer, Ian L Linde, et al.
The Annals of Thoracic Surgery|September 30, 2021
Inhibition of Cyclin Dependent Kinase 4/6 Overcomes Primary Resistance to Programmed Cell Death 1 Blockade in Malignant MesotheliomaHee-Jin Jang, Cynthia Y Truong, Eric M Lo, et al.
JTO Clinical and Research Reports|July 30, 2024
Pathophysiology and Management of Chest Wall Pain after Surgical and Non-Surgical Local Therapies for Lung CancerJohn Nikitas, Jane Yanagawa, Sandra Sacks, et al.
Pageof 16